Hamid Khoja, Chief Scientific Officer, FibroBiologics
08/24/2022 | Hamid Khoja | 4 min read
In regenerative medicines and therapeutics, fibroblasts can offer significant advantages over stem cells, says Hamid Khoja
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
You will benefit from:
Register
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal